PubMed=9538136; DOI=10.3892/ijo.12.5.1103
Toshiyuki Takaki, Akio Hiraki, Akiko Uenaka, Shinya Gomi, Kyogo Itoh, Heiichiro Udono, Akira Shibuya, Takao Tsuji, Sadayoshi Sekiguchi, Eiichi Nakayama;
Variable expression on lung cancer cell lines of HLA-A2-binding MAGE-3 peptide recognized by cytotoxic T lymphocytes.
Int. J. Oncol. 12:1103-1109(1998)

PubMed=10213231
Akio Hiraki, Toshihiko Kaneshige, Katsuyuki Kiura, Hiroshi Ueoka, Hiromishi Yamane, Motoyuki Tanaka, Mine Harada;
Loss of HLA haplotype in lung cancer cell lines: implications for immunosurveillance of altered HLA class I/II phenotypes in lung cancer.
Clin. Cancer Res. 5:933-936(1999)

PubMed=21048114; DOI=10.4049/jimmunol.1000225
Shingo Eikawa, Yoshihiro Ohue, Kenta Kitaoka, Toshiki Aji, Akiko Uenaka, Mikio Oka, Eiichi Nakayama;
Enrichment of Foxp3+ CD4 regulatory T cells in migrated T cells to IL-6- and IL-8-expressing tumors through predominant induction of CXCR1 by IL-6.
J. Immunol. 185:6734-6740(2010)

PubMed=22109656; DOI=10.1002/ijc.27359
Yoshihiro Ohue, Shingo Eikawa, Nami Okazaki, Yu Mizote, Midori Isobe, Akiko Uenaka, Minoru Fukuda, Lloyd John Old, Mikio Oka, Eiichi Nakayama;
Spontaneous antibody, and CD4 and CD8 T-cell responses against XAGE-1b (GAGED2a) in non-small cell lung cancer patients.
Int. J. Cancer 131:E649-E658(2012)